Seeking horses suffering from bone spavin

Veterinary group CEVA Animal Health is looking for horses that have been diagnosed as suffering with bone spavin to take part in a clinical trial of Tiludronate. The drug is already licensed and marketed in Europe under the name Tildren for the treatment of bone spavin and navicular disease.

In order for your horse or pony to be included in the trial a full lameness examination, including clinical examination, nerve blocks and radiography, will need to be completed by an orthopaedic expert.

Carol Phillips
Website editor

Carol is an experienced journalist and editor, who is also a passionate amateur rider and dedicated horse owner, having ridden since childhood. She has a particular interest in the emotional well-being and ethical training of horses, alongside veterinary matters, having garnered extensive first-hand experience of numerous equine health conditions through more than 30 years of horse ownership.